Objectives: The objective of this study was to develop a computer-aided detection system for automated brain metastases detection using magnetic resonance black-blood imaging and compare its applicability with conventional magnetization-prepared rapid gradient echo (MP-RAGE) imaging. Materials and Methods: Twenty-six patients with brain metastases were imaged with a contrast-enhanced, 3-dimensional, whole-brain magnetic resonance black-blood pulse sequence. Approval from the institutional review board and informed consent from the patients were obtained. Preprocessing steps included B1 inhomogeneity correction and brain extraction. The computer-aided detection system used 3-dimensional template matching, which measured normalized cross-correlation coefficient to generate possible metastases candidates. An artificial neural network was used for classification after various volume features were extracted. The same detection procedure was tested with contrast-enhanced MP-RAGE, which was also acquired from the same patients. Results: The performance of the proposed detection method was measured by the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity values. In the black-blood case, detection process displayed an AUROC of 0.9355, a sensitivity value of 81.1%, and a specificity value of 98.2%. Magnetization-prepared rapid gradient echo data showed an AUROC of 0.6508, a sensitivity value of 30.2%, and a specificity value of 99.97%.
T he use of magnetic resonance imaging (MRI) in patients with brain metastases has been reported as having higher diagnostic accuracy compared with other imaging modalities. 1Y3 However, visualizing and detecting small brain metastases still remain a difficult task, even with magnetic resonance (MR), and the use of higher field systems with higher spatial resolution and/or contrast agent doses has been suggested. 4 Along with dosage, comparison of metastases detectability using different types of contrast agents has also been conducted. 5 Furthermore, investigation of brain metastases' bloodbrain barrier permeability for development of novel treatment strategies has been reported. 6 For their detection, however, additional partial volume effects must also be overcome to detect small-sized brain metastases. To solve this, 3-dimensional (3D) T1-weighted magnetizationprepared rapid gradient-echo (MP-RAGE) imaging 7 is commonly used for detecting brain metastases. 8 One major drawback of applying contrast-enhanced MP-RAGE in imaging metastatic brain tumors is, however, that contrast material in tumor and blood both produce hyperintensities, causing difficulties in lesion detection. Although contrast-enhanced MP-RAGE can be combined with black-blood imaging methods such as double inversion recovery to suppress signal from blood, signal from blood recovers rapidly during the echo train of MP-RAGE and makes suppression difficult.
A contrast-enhanced, 3D whole-brain MR black-blood pulse sequence was developed, 9 wherein variable refocusing flip angles combined with flow-sensitizing gradients were used, in which moving blood is selectively suppressed while stationary tumor contrast remains apparent. Hence, this method can be useful in acquiring 3D brain data from patients with metastatic brain tumors. As an example, a comparison of identical image slices showing metastatic brain tumor imaged with contrast-enhanced MP-RAGE and black-blood imaging is shown in Figure 1 . As a natural result from the quality provided by the black-blood image, an automated detection scheme of metastatic tumor would seem applicable because signals originating from motional spins are suppressed in the black-blood pulse leaving hyperintense signal just from the tumor.
Along with advances in MR pulse sequence development, detection and accurate diagnosis of metastatic brain tumors can further benefit from computer-aided detection (CAD) systems. Computeraided detection systems were generally reported as improving radiologists' diagnostic accuracies, 10 with clinical applications such as detection and classification of lung nodules and a number of others.
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Previous CAD systems developed for MRI consists primarily of lesion detection and classification for breast MRI 12Y14 and prostate imaging. 15, 16 Several studies investigated CAD systems for detection and analysis of brain tumors. 17, 18 However, a common difficulty that most of the studies that used contrast-enhanced imaging faced was hyperintensities found in blood. Signals from blood frequently generate false positives and decrease the diagnostic accuracy of the CAD system in detecting lesions in the brain, yet previous studies focus primarily on postprocessing methods instead of the image acquisition strategy itself. In this study, the use of contrast-enhanced MR blackblood imaging for reduction of false positives from blood is suggested, along with a CAD system for discrimination of small brain metastases from false candidates based on optimized features that use image characteristics of MR black-blood imaging.
MATERIALS AND METHODS

Magnetic Resonance Data Sets
Patients suspected of metastatic brain tumor were imaged with a 3-T whole-body MR scanner (Magnetom Trio; Siemens Medical Solutions, Erlangen, Germany) using an 8-channel head coil with contrast-enhanced whole-brain black-blood imaging sequence. 9 The imaging sequence is a T1-weighted black-blood version of singleslab 3D turbo/fast spin echo, in which variable refocusing flip angles (VFA) with flow-sensitizing gradients were used to suppress the signal intensity of moving blood (repetition time/effective echo time, 650/ 11.7 milliseconds; the first refocusing flip angle (>_1), 180 degrees; the rest of refocusing flip angles, gray matter-specific prescription-based VFA; spatial resolution, 1.0 Â 1.0 Â 1.0 mm 3 ; and imaging time, 8.5 minutes). In particular, a nonselective radiofrequency (RF) excitation pulse was applied for excitation of the whole brain volume, followed by short nonselective refocusing RF pulses in the echo train, which reduce echo spacing and improves imaging efficiency. These refocusing RF pulses were joined with the VFA technique to reduce signal modulations during the data acquisition. Crusher gradients were placed on both sides of the refocusing pulses to increase the phase incoherence of the blood flow. Further details of the sequence are better described in the study of Park and Kim. 9 For comparison, data were acquired also with conventional MP-RAGE sequence, which is used as the standard protocol at our institution (repetition time/echo time/inversion time, 2200/4.4/900 milliseconds; flip angle, 10 degrees; resolution, 1.0 Â 1.0 Â 1.0 mm 3 ; and imaging time, 8.5 minutes). Informed written consents were obtained before the imaging, after the institutional review board's approval for the study.
Data sets acquired from the 26 patients had a total of 128 brain metastases that were identified by a board-certified radiologist (with 9 years of experience in neuroradiology). Apart from the previously mentioned data sets, 3 patient data were excluded from the study because of excessive motion artifacts. The number of tumors in each patient data and the distribution of tumor sizes are shown in Figure 2 . Before the data sets were separated, very small tumors (with diameters less than 1 mm; indicated in red in Fig. 2) were removed, reducing the total number of tumors used in this study to 90. Afterwards, the patient data sets were then randomly separated into training (33 tumors in 7 patients) and test (57 tumors in 19 patients) sets. The training sets were created separately for black-blood and MP-RAGE data sets, and the CAD system was optimized separately using respective training data. The tumors were divided into 3 size groups for correlation with templates.
Computer-Aided Detection System
A computer-aided metastatic brain tumor detection system was developed. The system has several subprocesses including B1 field inhomogeneity correction, brain extraction, normalized crosscorrelation coefficient (NCCC) template matching, clustering and prompting, feature extraction, followed by classification. The CAD system takes the 3D whole-brain volume as its input. A flow chart showing the overall algorithm is given in Figure 3 .
Preprocessing
Because of the nonselective inversion pulse used in the blackblood pulse sequence, the obtained data sets exhibit global intensity variation (central brightening) because of B1 field inhomogeneity effects. However, because the signal intensity information from tumors provide a major part of diagnosis criteria, elimination or reduction of such unwanted intensity inhomogeneity is necessary. With the assumption that most of the intensity variation is caused by B1 inhomogeneity effect, a low-frequency image was created using the central portions of k-space and was divided from the original image to eliminate central brightening.
Afterward, a semiautomatic brain extraction process was incorporated. The brain extraction for all data sets of the 26 patients was done using a 3D segmentation tool included in Analyze 9.0 (Mayo Clinic). The extraction process was based on a gradient magnitude edge-detection and watershed segmentation method with manually selected seed points. The binary mask was then multiplied to the original image to extract brain parenchyma.
Tumor Candidate Generation
Brain metastases are generally described as having spherical shapes and well-expressed tumor-brain boundaries compared with other anatomical structures 19, 20 in contrast-enhanced MR images. Tumor candidates were generated and spatially separated from the background brain tissues by using these characteristics. A 3D spherical-shaped template with a variable diameter was modeled. The diameters of these templates range from 4 to 12 voxels, which were decided on the basis of general tumor sizes found in the training set. Although using different spatial models to compensate for the partial volume effects has previously been suggested, 21 features that measure candidate orientation within the spatially separated volume were also included in the feature extraction process. This reduced the processing time, compared with using additional template models.
The template models were matched with each voxel of the input data set to detect voxels with similarity value greater than a set threshold. The degree of similarity was measured using an NCCC. 22 Specifically, the NCCC value was obtained using the following formula: where t is the spherical template model,t ; is the mean value of the template model, f is the image intensity, and f ; is the mean value of the intensity. Averaging is performed over the image voxel position x, y, z under the template window position at u, v, w. Representative voxels with higher NCCC values than a set threshold value are retrieved for coordinate identification and clustering. The NCCC threshold used throughout the study was determined using the training set (data sets 1Y7) to ensure that the process is generalizable.
By setting the voxels with NCCC value greater than the threshold as a candidate representative voxel, neighboring voxels were clustered as a single candidate by selecting and grouping neighboring candidates that were within the template-sized volume. Although some voxels that are not actually part of the tumor were included in the candidate volume, voxels that made up tumors provided significantly higher signal intensities compared with the surrounding brain tissue inside the candidate volume and features that accounted for this characteristic were included during feature extraction.
Feature Extraction
Several features were extracted from each candidate volume for classification. Features consisted primarily of gray-level information of and the candidate volume. The mean and SD of signals from the candidate volumes were included. To measure the candidate orientation, the number of voxels with below-average signal intensity and the number of voxels with zero signal intensity within the candidate volume were also included. Because most tumors generate within the brain parenchyma, this feature allowed discrimination from any residual signal from blood by using the characteristics of black-blood images. The last group of features included the measure of tumor circularity. With the assumption that tumor parenchyma appears as spheres, circularity of each template was measured by calculating the ratio of the length of the candidate axis (x-y, y-z, z-x).
Data Analysis
Classification was performed using an artificial neural network (ANN) pattern recognition method. The artificial neural network classifier automatically randomized the input tumor candidates and used 20% of them as validation set. The validation set were used to measure network generalization and, also, to stop the training process when the generalization seized to improve. The neural network was trained to discriminate true brain metastasis from false-positive candidates on the basis of extracted features from each candidate. The network was trained with scaled conjugate gradient back-propagation algorithm 23 with 20 hidden neurons. Sigmoid functions were used as activation functions.
The detection accuracy of the CAD system was measured qualitatively by the receiver operating characteristic (ROC) curve of the classifier outputs, the AUROC, along with sensitivity and specificity values. All analyses were done using MATLAB (version R2011a; Mathworks). To determine the optimum threshold value for the NCCC, the multiple detection procedure was conducted with varying threshold and its effect on sensitivities, specificities, and the number of candidates generated was investigated. The same process was performed for the MP-RAGE data set, and results from conventional MP-RAGE sequence and black-blood sequence are provided.
RESULTS
A sample result of B1 inhomogeneity artifact correction during the preprocessing step is shown in Figure 4 . Central brightening seen in all 3 directions is eliminated by dividing by the low-frequency FIGURE 5. Sample images from the proposed detection process for metastatic brain tumors with black-blood MR imaging: Input image with central brightening effect removed (A), result of brain extraction with Analyze 9.0 (B), NCCC ''map'' created during template matching process, with bright regions indicate high correlation with template (C), and tumor candidate generated after the template matching (D).
FIGURE 6.
Threshold sweep results using the training data sets: the sweep result for sensitivity and specificity (A) and the number of candidates generated at each threshold sweep value (B).
image. This was an important preprocessing step to homogenize the overall intensity variation of the black-blood sequence. The number of seed points required for creating accurate mask volume for brain extraction step varied from 5 to 15, depending on factors such as brain morphology, severity of metastasis, and image quality factors such as signal-to-noise ratio (SNR) and amount of artifacts.
The overall brain extraction process required around 9 to 10 minutes per patient data set. Representative images from each step up to the candidate generation are shown in Figure 5 . The optimum threshold value for NCCC template matching was determined by conducting multiple detection procedures with varying threshold values with the training data set. The result of this threshold sweep is shown in Figure 6 . Although the sensitivities tend to decrease after each step in the detection process, there is clearly an optimum value (in this case, the threshold of 0.2863) that will consistently give both good sensitivity and specificity. It can be seen in Figure 6A that the performance of the detection process peaks at 0.2863, whereas other threshold values display comparably lesser performance. Along with sensitivity/specificity, the number of candidates generated by each threshold value varies also. As shown in Figure 6B , the number of candidates generated after NCCC template matching increases exponentially as the threshold value is lowered. This depicts a trade-off between detection accuracy and processing time. This inherent tradeoff should be taken into concern to determine the range of performance of the overall detection process.
From the 19 test data sets with a total of 53 tumors used for this study, contrast-enhanced black-blood sequence produced a total of 488 tumor candidates during the template matching process. The optimum threshold value determined for the black-blood data was 0.2863. With this threshold, the detection system gave 81.1% (43 of the 53 tumors identified) sensitivity and 98.2% (435 of 443 nontumors identified) specificity, along with an AUROC value of 0.9355. The threshold for the data acquired with MP-RAGE sequence was 0.2626 with a total of 5839 tumor candidates generated for the test set. The detection system gave 30.2% (16 of the 53 tumors) sensitivity and 99.97% (5786 of 5788 nontumors) specificity, with an AUROC value of 0.6508. Confusion matrices showing summary of test set results for both cases and respective ROC curves are shown in Figure 7 and 8. Sensitivities and specificities are indicated in the bottom left and middle squares, respectively. In terms of false positives and false negatives, the black-blood data gave 0.42 false positives (FP) per data set (8 FP in 19 patient data) and 0.53 false negatives (FN) per data set (10 FN in 19 patient data), whereas the MP-RAGE data gave 0.11 FP per data set (2 FP in 19 patient data) and 1.95 FN per data set (37 FN in 19 patient data). Note that the total number of candidates generated from black-blood data is 8.4% (488/5839) of the MP-RAGE case, with a significantly shorter processing time. Although the MP-RAGE case used lower NCCC threshold value, the sensitivity is lower than that of the black-blood case. The low threshold also resulted in generation of excessive amount of true-negative candidates, which is reflected as high specificity value.
DISCUSSION
In this study, an automated detection scheme for metastatic brain tumors from contrast-enhanced MR black-blood imaging data was developed. Tumor candidates were detected and spatially separated from the input volume by 3D spherical template matching that measures NCCC. After the possible tumor candidates were listed, various volume features were extracted from each candidate for discrimination process using an artificial neural network classifier. The performance was compared with conventional MP-RAGE.
By incorporating a neural network classifier, the number of candidates generated from the template matching process can be effectively reduced by prompting only those candidates within the true positive category. This is beneficial, in a clinical sense, because a fewer number of candidates prompted for possible tumor candidate could help reduce the total time required for radiologists'data reading. A common difficulty that studies involving automated detection faced was the high number of FPs per data set. With our method, however, the number of FP can be significantly reduced. Among the 6 patients with no metastasis, although many tumor candidates were generated, no FP arose from these data sets after the ANN classifier. Furthermore, although some tumors were misclassified as negatives, the performance of the classifier could be improved by training the classifier with a larger training data set that contains more diverse tumor morphology.
Using fast spin-echo-based black-blood imaging sequence increased the accuracy of metastatic brain tumor detection compared with contrast-enhanced MP-RAGE sequence, which is a common imaging sequence used for viewing metastatic brain tumors. No increase in scan time was needed. The number of FPs in both cases is in manageable ranges, but low sensitivity and excessive number of total candidates in MP-RAGE case prevent accurate discrimination of true tumor candidates. Although sensitivity can be increased in the MP-RAGE case, this will also increase the number of total candidates, increasing the processing time and creating bias during classification process. Although our comparison was limited to MP-RAGE, different pulse sequences are used for the detection of metastatic brain tumors. However, previous articles on comparison of different imaging sequences for the detection of metastases are predominantly based on readings of radiologists rather than CAD applications. Because most CAD systems applied to diagnostic radiology are not perfect, our CAD method was developed to facilitate the daily routine work of radiologists by screening in advance. As previous studies showed, even experienced radiologists often miss some lesions. 28 Therefore, we believe our CAD system may help them improve diagnostic sensitivity. However, further comparison study including 2 or more radiologists should be followed.
Signal-to-noise ratio and image resolution are important factors in the detection of metastatic brain tumors, especially for the detection of tumor nodules that are very small (È1 voxel). A typical example of these tumors is shown in Figure 9 . As shown, accurate description of these tumors requires a submillimeter-or at least a millimeter-level image resolution and a high SNR to increase the number of voxels that compose the target tumor and enable various features to be extracted from them. Although not shown, our detection algorithm was tested to detect these tumors using a single template with a diameter of 2 mm for the contrast-enhanced black-blood data. The method found difficulty in detecting these tumors during the template matching process because many of these nodules did not display sufficient signal intensity and many were not contained well within a voxel. Although reducing the NCCC threshold could detect these tumors, it was inefficient because nearly 400 candidates were generated with threshold value of 0.2750 for each data set, which would have a total of more than 7000 candidates.
Detection of these individual tumors with diameters that are less than 1 mm is important, and our current CAD system is limited because these diameters were avoided from the study. Meanwhile, reports have shown that clinical treatment decision making for patients with metastatic brain tumor can depend on the number of total tumors present and their exact positions.
29Y32 Therefore, the usefulness of our system can be more on assisting radiologists for the initial screening of approximate tumor count. In addition, a previous report on detection accuracy of brain metastases of such small sizes by radiology residents and board-certified radiologists found that complete detection of these tumors are difficult, even to trained human readers. 25 Our further study is therefore mainly focused on the detection of these small tumors. A combination of development of highresolution, high-SNR MR black-blood imaging sequence along with a postprocessing technique for selectively enhancing the contrast of small objects could increase the detectability of these tumors. Compared with other imaging modalities, MR can be a robust screening method for metastatic brain tumors because imaging pulse sequence can be relatively easily optimized for accurate visualization of tumor parenchyma.
In this study, a spherical-shaped template was assumed, where large tumors that deviate from this assumption (tumors with necrotic centers, etc) and tumors that are nonspherically shaped were discarded from the study. These tumors present the limitation of our detection method, although it is clinically accepted that metastatic brain tumors are generally spherical. 33, 34 In conclusion, an automated detection method for metastatic brain tumors using MR black-blood data with 3D template matching method was presented. The detection method took in 3D MR blackblood volume as its input, and preprocessing steps such as B1 field inhomogeneity correction and brain extraction were included. Spherical templates of various diameters were constructed and matched with the input volume to generate tumor candidates. With various features extracted from each candidate, an artificial neural network classifier was incorporated to discriminate tumors from false candidates. The results of our study demonstrate that accurate automated detection of metastatic brain tumors using contrast-enhanced black-blood imaging sequence is possible compared with using conventional MP-RAGE sequence with both high sensitivity and specificity. Such detection method can possibly assist radiologists during the interpretation and detection of MR images of metastatic brain tumors.
